Transcept Pharmaceuticals News

Purdue Pharmaceuticals LP will shelve 90 contract sales people it used to exclusively hawk the Transcept Pharmaceuticals Inc.-developed middle-of-the-night sleep drug Intermezzo.

TSPT has been the subject of a number of other recent research reports. Analysts at JMP Securities downgraded shares of Transcept Pharmaceuticals Incorporated to a "market perform" rating in a research note to investors on Thursday.

Good day, ladies and gentlemen, and welcome to the Transcept First Quarter 2013 Earnings Conference Call.

Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Wednesday, May 8, 2013, at 4:30 p.m. Eastern Time to discuss its first ... (more)

Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Thomas J. Dietz, Ph.D., Chairman and CEO of Waypoint Holdings, LLC, a financial holdings and services company, has ... (more)